Sertraline for the treatment of depression in Alzheimer’s disease: Week-24 outcomes

BACKGROUND: Depression and antidepressant use are common in Alzheimer’s disease (AD), but the effect of antidepressant treatment for depression on longer-term outcomes is unknown. We report the week-24 outcomes of patients who participated in a 12-week efficacy study of sertraline for depression of...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Weintraub, Daniel, Rosenberg, Paul B., Drye, Lea T., Martin, Barbara K., Frangakis, Constantine, Mintzer, Jacobo E., Porsteinsson, Anton P., Schneider, Lon S., Rabins, Peter V., Munro, Cynthia A., Meinert, Curtis L., Lyketsos, Constantine G.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2849739/
https://ncbi.nlm.nih.gov/pubmed/20220589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JGP.0b013e3181cc0333
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky